These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7813558)

  • 1. Profiles of emetic action of cisplatin in the ferret: a potential model of acute and delayed emesis.
    Rudd JA; Jordan CC; Naylor RJ
    Eur J Pharmacol; 1994 Sep; 262(1-2):R1-2. PubMed ID: 7813558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An interaction of ondansetron and dexamethasone antagonizing cisplatin-induced acute and delayed emesis in the ferret.
    Rudd JA; Naylor RJ
    Br J Pharmacol; 1996 May; 118(2):209-14. PubMed ID: 8735616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Action of metyrapone and tetracosactrin to modify cisplatin-induced acute and delayed emesis in the ferret.
    Sam TS; Kan KK; Ngan MP; Rudd JA; Yeung JH
    Eur J Pharmacol; 2003 Apr; 466(1-2):163-8. PubMed ID: 12679153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Action of glucocorticoids to antagonise cisplatin-induced acute and delayed emesis in the ferret.
    Sam TS; Chan SW; Rudd JA; Yeung JH
    Eur J Pharmacol; 2001 Apr; 417(3):231-7. PubMed ID: 11334855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-emetic activity of the novel nonpeptide tachykinin NK1 receptor antagonist ezlopitant (CJ-11,974) against acute and delayed cisplatin-induced emesis in the ferret.
    Tsuchiya M; Fujiwara Y; Kanai Y; Mizutani M; Shimada K; Suga O; Ueda S; Watson JW; Nagahisa A
    Pharmacology; 2002 Nov; 66(3):144-52. PubMed ID: 12372904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using telemetry to automate the detection of emesis in the ferret: new vistas for delayed emesis assessment.
    Goineau S; Rompion S; Guillaume P; Barrais L; Castagné V
    J Pharmacol Toxicol Methods; 2013; 68(1):160-5. PubMed ID: 23578691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tachykinin NK1 receptor antagonist PD 154075 blocks cisplatin-induced delayed emesis in the ferret.
    Singh L; Field MJ; Hughes J; Kuo BS; Suman-Chauhan N; Tuladhar BR; Wright DS; Naylor RJ
    Eur J Pharmacol; 1997 Feb; 321(2):209-16. PubMed ID: 9063690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel NK1 receptor antagonist MK-0869 (L-754,030) and its water soluble phosphoryl prodrug, L-758,298, inhibit acute and delayed cisplatin-induced emesis in ferrets.
    Tattersall FD; Rycroft W; Cumberbatch M; Mason G; Tye S; Williamson DJ; Hale JJ; Mills SG; Finke PE; MacCoss M; Sadowski S; Ber E; Cascieri M; Hill RG; MacIntyre DE; Hargreaves RJ
    Neuropharmacology; 2000 Feb; 39(4):652-63. PubMed ID: 10728886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The action of the NK1 tachykinin receptor antagonist, CP 99,994, in antagonizing the acute and delayed emesis induced by cisplatin in the ferret.
    Rudd JA; Jordan CC; Naylor RJ
    Br J Pharmacol; 1996 Nov; 119(5):931-6. PubMed ID: 8922742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin-induced emesis in the Ferret: a new animal model.
    Florczyk AP; Schurig JE; Bradner WT
    Cancer Treat Rep; 1982 Jan; 66(1):187-9. PubMed ID: 7198011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Action of (R)-sila-venlafaxine and reboxetine to antagonize cisplatin-induced acute and delayed emesis in the ferret.
    Warneck JB; Cheng FH; Barnes MJ; Mills JS; Montana JG; Naylor RJ; Ngan MP; Wai MK; Daiss JO; Tacke R; Rudd JA
    Toxicol Appl Pharmacol; 2008 Nov; 232(3):369-75. PubMed ID: 18675289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resiniferatoxin antagonizes cisplatin-induced emesis in dogs and ferrets.
    Yamakuni H; Sawai-Nakayama H; Imazumi K; Maeda Y; Matsuo M; Manda T; Mutoh S
    Eur J Pharmacol; 2002 May; 442(3):273-8. PubMed ID: 12065081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Action of cyclooxygenase inhibitors and a leukotriene biosynthesis inhibitor on cisplatin-induced acute and delayed emesis in the ferret.
    Sam TS; Ngan MP; Riendeau D; Robichaud A; Rudd JA
    J Pharmacol Sci; 2007 Feb; 103(2):189-200. PubMed ID: 17310074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tachykinin NK1 receptor antagonist CP-99,994 attenuates cisplatin induced emesis in the ferret.
    Tattersall FD; Rycroft W; Hargreaves RJ; Hill RG
    Eur J Pharmacol; 1993 Nov; 250(1):R5-6. PubMed ID: 8119305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated analysis of delayed emesis in the telemetered ferret: detection of synergistic effects of aprepitant and ondansetron.
    Goineau S; Guillaume P; Barrais L; Castagné V
    Fundam Clin Pharmacol; 2014 Dec; 28(6):643-51. PubMed ID: 24750138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emesis induced by cisplatin in the ferret as a model for the detection of anti-emetic drugs.
    Costall B; Domeney AM; Naylor RJ; Tattersall FD
    Neuropharmacology; 1987 Sep; 26(9):1321-6. PubMed ID: 2890117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the abdominal visceral innervation and 5-hydroxytryptamine M-receptors in vomiting induced by the cytotoxic drugs cyclophosphamide and cis-platin in the ferret.
    Hawthorn J; Ostler KJ; Andrews PL
    Q J Exp Physiol; 1988 Jan; 73(1):7-21. PubMed ID: 3347698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of three preclinical models for nausea and vomiting assessment.
    Goineau S; Castagné V
    J Pharmacol Toxicol Methods; 2016; 82():45-53. PubMed ID: 27477617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The growth hormone secretagogue receptor 1a agonists, anamorelin and ipamorelin, inhibit cisplatin-induced weight loss in ferrets: Anamorelin also exhibits anti-emetic effects via a central mechanism.
    Lu Z; Ngan MP; Liu JYH; Yang L; Tu L; Chan SW; Giuliano C; Lovati E; Pietra C; Rudd JA
    Physiol Behav; 2024 Oct; 284():114644. PubMed ID: 39043357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-emetic activity of ghrelin in ferrets exposed to the cytotoxic anti-cancer agent cisplatin.
    Rudd JA; Ngan MP; Wai MK; King AG; Witherington J; Andrews PL; Sanger GJ
    Neurosci Lett; 2006 Jan; 392(1-2):79-83. PubMed ID: 16182445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.